Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Crystal structure of human AKR1B1 complexed with NADP+ and compound 41[OXIDOREDUCTASE]
View in iCn3D Similar StructuresPubMedProteinsConserved DomainsPubChem Compound
Crystal structure of human AKR1B1 complexed with NADP+ and compound 39[OXIDOREDUCTASE]
Crystal structure of human AKR1B1 complexed with NADP+ and compound 37[OXIDOREDUCTASE]
Human Aldose Reductase structure[OXIDOREDUCTASE]
Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at 1.02 A[OXIDOREDUCTASE]
View in iCn3D Similar StructuresProteinsConserved DomainsPubChem Compound
Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A[OXIDOREDUCTASE]
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049[OXIDOREDUCTASE]
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048[OXIDOREDUCTASE]
Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)[oxidoreductase/oxidoreductase inhibitor]
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A[oxidoreductase/oxidoreductase inhibitor]
Crystal structure of human AR complexed with NADP+ and AK198[OXIDOREDUCTASE]
Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A[oxidoreductase/oxidoreductase inhibitor]
Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A[oxidoreductase/oxidoreductase inhibitor]
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A[Oxidoreductase/Oxidoreductase inhibitor]
Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A[Oxidoreductase/Oxidoreductase inhibitor]
Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID) at 0.96 A[Oxidoreductase/Oxidoreductase inhibitor]
Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1.01 A[Oxidoreductase/Oxidoreductase inhibitor]
Human Aldose Reductase complexed with Schl7802 at 1.06 A[Oxidoreductase/Oxidoreductase inhibitor]
Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A[oxidoreductase/oxidoreductase inhibitor]
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid[OXIDOREDUCTASE]
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on